Full text is available at the source.
Abstract
Approximately one-third of patients with epilepsy experience drug-resistant epilepsy (DRE).
- DRE is associated with notable changes in gut microbiota composition.
- Interventions aimed at modifying the gut microbiota show potential therapeutic benefits.
- Current pharmacological strategies for specifically targeting gut microbiota in DRE are limited.
Simplified